Similarly, some monocyte fractions of severely ill COVID-19 patients failed to show enhanced LGALS3BP upregulation in our scRNA-seq analysis (cohort A), whereas mildly affected patients displayed distinct upregulation. This evidence concerns the gene LGALS3BP and COVID-19.